PRESS RELEASE January 5 , 202 2 Saniona (OMX: SANION), a clinical - stage biopharmaceutical company focused on rare diseases, today announced that it will present at multiple upcoming virtual investor conferences. Details are as follows: LifeSci Partners 11th Annual Corporate Access Event (Panel